Heart Failure: Device Management
January 2010, Wiley-Blackwell
In clear, straightforward prose, Dr. Feldman addresses:
- Resynchronization Therapy
- Impulse Therapy
- Chronic Implantable Monitoring
- and more
With chapters devoted to monitoring the patient on device therapy and the future of device therapy in heart failure, this book makes an important contribution to patient care.
Chapter One: Cardiac Resynchronization Therapy (Behzad Pavri and Arthur M. Feldman).
Chapter Two: Implantable Cardioverter-Defibrillator Therapy (Reginald T. Ho and Arnold J.Greenspon).
Chapter Three: Chronic Implantable Monitoring (Nisha Aggarwal and David J. Whellan).
Chapter Four: Cardiac Contractility Modulation by Electrical Signals Applied During Absolute Refractory Period as a Treatment for Chronic Heart Failure (Daniel Burkhoff, Hani N. Sabbah, Christian Butter, Yuval Mika and Martin Borggrefe).
Chapter Five: Role of Cardiac Restraint Devices in the Treatment of Patients with Dilated Cardiomyopathy (Douglas L. Mann).
Chapter Six: The Role of Right Heart Catherization in Management of Patients with Heart Failure (Sandeep A. Kamath and Mark H. Drazner).
Chapter Seven: Impedance Cardiography (Sunthosh V. Parvathaneni and Ileana L. Pina).
Chapter Eight: The Use of Echocardiography in Evaluating the Heart Failure Patient and Response to Therapy (John Gorscan III).
Chapter Nine: Revascularization for Left Ventricular Dysfunction (Nicholas J. Ruggiero II, Thomas J. Kiernan, Juan M. Bernal and Igor F. Palacios).
Chapter Ten: Minimally Invasive Treatment of Mitral Valve Disease (Andra Popescu and Paul J. Mather).
Chapter Eleven: Percutaneous Mechanical Assist Devices (Suresh Mulukutla, Lawrence Schneider and Howard A. Cohen).
Chapter Twelve: Left Ventricular Assist Devices for Acute and Chronic Heart Failure (Daniel Marelli, Louis Stein, Abbas Ardehali).
Chapter Thirteen: The Role of Enhanced External Counterpulsation (EECP) in Heart Failure Management (Marc A. Silver and William E. Lawson).
Chapter Fourteen: Ultrafiltration (Maria Rosa Constanzo).
Conflict of Interest Table.
After receiving his B.A. degree from Gettysburg College, and M.S. and Ph.D. degrees from the University of Maryland, Dr. Feldman served as a post-doctoral fellow in physiology at the Johns Hopkins University School of Medicine. After completing his medical degree at the Louisiana State University School of Medicine, he returned to Johns Hopkins where he served as an intern, resident and cardiology fellow.
After joining the faculty in 1985, he was named the Director of the Belfer Laboratory for Molecular Biology of Heart Failure and the Director of the Heart Failure Research Program at The Johns Hopkins University School of Medicine. In 2004 Dr. Feldman joined the faculty at the University of Pittsburgh School of Medicine as the Harry S. Tack Professor of Medicine, Chief of the Division of Cardiology, and Director of the Cardiovascular Institute of the UPMC Health System.
In 2002, Dr. Feldman was named the Magee Professor of Medicine and Chairman of the Department of Medicine at Jefferson Medical College. He is a past President of the Heart Failure Society of America and of the Association of Professors of Cardiology. He has served on the editorial boards of many scientific journals and was elected to membership in organizations including Alpha Omega Alpha, the Association of University Cardiologists, the American Society for Clinical Investigation and the Association of American Physicians.
He has published over 200 peer-reviewed articles. Dr. Feldman's research has focused on molecular and clinical aspects of heart failure. Most recently he has chaired the Steering Committees for the PEECH, EMOTE and WEAR-IT trials and co-chaired the COMPANION study.